April 2026
The global stomach cancer treatment market size is estimated to surpass around USD 19.42 billion by 2035 from USD 6.08 billion in 2025, with a solid CAGR of 12.31%.
April 2026
The global ovarian cancer drugs market size was evaluated at USD 4.09 billion in 2025 and is predicted to hit around USD 7.78 billion by 2035, growing at a CAGR of 6.64%.
March 2026
The global cancer biologics market size is calculated at USD 117.45 billion in 2025 and is predicted to increase from USD 126.02 billion in 2026 to approximately USD 235.81 billion by 2035, expanding at a CAGR of 7.22% from 2026 to 2035.
March 2026
The global cervical cancer diagnostic market size is calculated at USD 9.82 billion in 2025 and is predicted to increase from USD 10.33 billion in 2026 to approximately USD 16.04 billion by 2035, expanding at a CAGR of 5.03% from 2026 to 2035.
March 2026
The global kidney cancer drugs market size is calculated at USD 7.24 billion in 2025 and is projected to hit around USD 12.16 billion by 2035 with a CAGR of 5.32%.
March 2026
The global cancer registry software market size is expected to increase from USD 84.16 million in 2025 to hit around USD 273.29 million by 2034, with a CAGR of 12.50%.
March 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 1.93 billion in 2025 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
February 2026
The global metastatic non-small cell lung cancer market size was evaluated at USD 18.50 billion in 2025 and is predicted to hit around USD 50.30 billion by 2035, growing at a CAGR of 10.52%.
February 2026
The global lung cancer surgery market size was evaluated at USD 1.55 billion in 2025 and is predicted to hit around USD 2.76 billion by 2035, growing at a CAGR of 5.95%.
February 2026
The global prostate cancer diagnostics market size is expected to hit around USD 18 billion by 2035 from USD 9.72 billion in 2025, with a CAGR of 6.36%.
February 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.21 billion in 2025 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
February 2026
The global breast cancer market size was estimated at USD 26.23 billion in 2025 and is predicted to increase from USD 27.37 billion in 2026 to approximately USD 40.11 billion by 2035, expanding at a CAGR of 4.34% from 2026 to 2035.
February 2026
The global genomics in cancer care market size was evaluated at USD 24.39 billion in 2025 and is predicted to hit around USD 108.69 billion by 2035, growing at a CAGR of 28.32%.
February 2026
The global cancer diagnostics market size is calculated at USD 170 billion in 2025 and is predicted to increase from USD 184.96 billion in 2026 to approximately USD 378.44 billion by 2035, expanding at a CAGR of 8.33% from 2026 to 2035.
February 2026
The cancer immunotherapy market size is calculated at USD 136.39 billion in 2025 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
January 2026
The global cancer biomarkers market size was estimated at USD 15.58 billion in 2025 and is projected to hit around USD 47.14 billion by 2035 with a CAGR of 11.71%.
January 2026
The global peptide-based cancer therapeutics market size was evaluated at USD 9.47 billion in 2025 and is predicted to hit around USD 24.85 billion by 2035, growing at a CAGR of 10.13%.
January 2026
The global non-invasive cancer diagnostics market size was calculated at USD 173.13 billion in 2025 and is predicted to increase from USD 185.94 billion in 2026 to approximately USD 350.78 billion by 2035, expanding at a CAGR of 7.32% from 2026 to 2035.
December 2025
The global small cell lung cancer therapeutics market size is valued at USD 7.25 billion in 2025 and is predicted to increase from USD 8.14 billion in 2026 to approximately USD 22.86 billion by 2035, expanding at a CAGR of 12.17% from 2026 to 2035.
December 2025
The global prostate cancer market size is calculated at USD 12.88 billion in 2025 and is predicted to increase from USD 13.97 billion in 2026 to approximately USD 28.83 billion by 2035, expanding at a CAGR of 8.50% from 2026 to 2035.
December 2025
The global cancer supportive care drugs market size is projected to hit around USD 27.45 billion by 2035 from USD 22.31 billion in 2025 with a CAGR of 2.09%.
December 2025
The global breast cancer core needle biopsy market size is evaluated at USD 1.03 billion in 2025 and is predicted to hit around USD 1.63 billion by 2035, growing at a CAGR of 4.72%.
December 2025
The global gastric cancer diagnostics market size is evaluated at USD 1.32 billion in 2025 and is predicted to hit around USD 2.72 billion by 2035, growing at a CAGR of 7.51%.
December 2025
The cancer biopsy market size is estimated at USD 36.55 billion in 2025 and is expected to hit around USD 196.68 billion by 2035, growing at a CAGR of 18.33%.
December 2025
The oncology/cancer drugs market size is calculated at USD 192.39 billion in 2025 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
November 2025
The global pancreatic cancer precision medicine market size is estimated to hit around USD 4,030.16 million 2034 increasing from USD 823.30 million in 2025, with a CAGR of 19.30%.
November 2025
The global skin cancer diagnostic market size is evaluated at USD 8.97 billion in 2025 and is predicted to hit around USD 13.96 billion by 2034, with a CAGR of 5.04%.
November 2025
The global lung cancer diagnostics market size is estimated at USD 5.35 billion in 2025 and is predicted to hit around USD 9.45 billion by 2034 with a CAGR of 6.53%.
November 2025
The global next generation cancer diagnostics market size is valued at USD 19.16 billion in 2025 and is predicted to increase from USD 20.70 billion in 2026 to approximately USD 38.36 billion by 2034, expanding at a CAGR of 8.02% from 2025 to 2034.
November 2025
The global endometrial cancer market size is calculated at USD 31.09 billion in 2025 and is expected to reach around USD 51.15 billion by 2034, expanding at a CAGR of 5.69% from 2025 to 2034.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com